Healthcare Interoperability Solutions Market

Healthcare Interoperability Solutions Market by Type (Software (EHR, Lab System, Imaging, Health Information Exchange, Enterprises), and Services), Interoperability Level (Foundational, Structural, Semantic), End User, and Region - Global Forecast to 2027

Report Code: HIT 6989 Mar, 2023, by marketsandmarkets.com

Updated on : April 03, 2023

The global healthcare interoperability solutions market in terms of revenue was estimated to be worth $3.4 billion in 2022 and is poised to grow at a CAGR of 12.9% from 2022 to 2027.

The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. Growth in this market is driven by the government funding to increase adption of healthcare interoperability solutions, and the emergence of new technologies. However, increasing complexity due to lack of consistent data is challenging towards growth of the market to a certain extent during the forecast period.

Global Healthcare Interoperability Solutions Market Trends

Healthcare Interoperability Solutions Market

To know about the assumptions considered for the study, Request for Free Sample Report

Healthcare Interoperability Solutions Market

Healthcare interoperability solutions Market Dynamics

Drivers: Emergence of new medical technologies

Technological advances over the last several decades have been on the rise. However, the cost of some of these technological advances is what is partially responsible for the overall increase in healthcare costs. In fact, new medical technologies are responsible for 40–50% of annual cost increases. Healthcare interoperability has several potential benefits. Well-communicating systems can improve operational efficiency, thereby reducing the time spent on administrative tasks such as manually entering data received from faxes. Interoperability can also reduce duplicate clinical interventions such as imaging studies or lab orders, thus decreasing waste and overall costs and also improving patient safety by reducing exposure to radiation or invasive procedures. Finally, interoperability may also improve clinical care by facilitating improved access to relevant and longitudinal clinical data at the point of care. FHIR, or Fast Healthcare Interoperability Resources, is an open-source standards framework for healthcare data that draws on HL7, a previous standards framework. FHIR was developed to facilitate the transfer of healthcare data from one system to another.

Restraints: Lack of accurate interoperability solutions across healthcare supply chain

The lack of accurate interoperability between healthcare providers, systems, technology, and information is a challenge across the healthcare supply chain. Diverse vendors, processes, and standards all obstruct the delivery of optimal patient results. Increasing healthcare expenditures, increased patient expectations, and a movement to value-based care requires providers to improve healthcare interoperability. The lack of true interoperability among electronic systems is a major concern. While many hospitals are able to use their current EHRs for some information exchange activities that promote interoperability (such as finding, sending, or receiving information), only 23% of hospitals can perform all four information exchange activities (find, send, receive, and use).

Opportunities: Advancements in software technology for real-time data exchange

The capacity of different solutions to freely and readily communicate with one another is referred to as software interoperability. Interoperable systems exchange data in real time without the need for specialized IT assistance or behind-the-scenes code. It might be as simple as a customer relationship management (CRM) system that integrates deeply with automation software to generate a data flow between sales and marketing. Alternatively, the team may set up a whole tech stack comprised of interconnected apps that communicate data to stramline procedures. The purpose of software interoperability is to eliminate data silos. This is getting increasingly crucial as the number of platforms and applications used. Some of the trends in market are HL-7 FHIR, Big data, Deep interoperability, EHR integration.

Challenges: Increasing complexity due to lack of consistent data

The healthcare IT landscape has grown increasingly vast and complex, with each department in a healthcare facility having its own IT system, from emergency services to imaging, laboratories, and patient wards. With the sheer volume of healthcare data that a hospital generates on a daily basis, healthcare facilities all around the world are under pressure to enhance efficiency and patient outcomes. The proliferation of technologically complex medical equipment, hidden pockets of unstructured data, and a lack of system compatibility limit their capacity to do more with the data they collect. Making disparate medical systems interoperable and wrangling patient record data from siloed hospital departments is important for several reasons—extracting data from hidden siloes takes valuable time away from the patient. There is also the chance that critical data could be missed. Devices and systems that can connect with each other and share data have the potential to enable a 360-degree view of the patient’s health, allowing clinicians to make faster and more responsive decisions, which is behind the drive to prioritize interoperability in hospital IT systems.

Healthcare Interoperability Solutions Market Ecosystem

Prominent companies in this market include well-established manufacturers and service providers of healthcare interoperability Solutions. These companies have been operating in the market for several years and possess a diversified product portfolio, organic & inorganic strategies, strong global sales and marketing networks. Prominent companies in this market include Oracle Health (US), Epic Systems Corporation (US), Infor, Inc. (US), InterSystems Corporation (US), Koninklijke Philips N.V. (Netherlands), Veradigm LLC (US), Cognizant (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), Merative (US), Medical Information Technology, Inc. (US), and Lyniate (US).

Healthcare interoperability solutions Market Map

Healthcare Interoperability Solutions Market Ecosystem

Healthcare Interoperability Solutions Market Ecosystem

EHR interoperability solutions segment accounted for the largest share in the healthcare interoperability solutions market for software in 2021

On the basis of type, the EHR interoperability solutions segment accounted for the largest share in the market for software in 2021. The large share of the EHR interoperability solutions segment can be attributed to the large installed base of EHR solutions and the growing need to make these EHR systems interoperable to facilitate quick decision-making

Healthcare providers is the largest end user segment in the healthcare interoperability solutions market in 2021

Based on end user, the healthcare providers segment is expected to register the highest CAGR during the forecast period. Factors responsible for the growth of this segment are increasing volume of patient data pertaining to increasing hospital enteries, shift towards quality-based care.

APAC region of healthcare interoperability solutions market to witness the highest growth rate during the forecast period.

The Asia Pacific market is projected to grow at the highest CAGR during the forecast period. Market growth in the APAC region is mainly driven by factors such as technological revolution in the region, growing penetration of smart gadgets, shift towards digitalization to ensure patient safety as well as streamline operationin healthcare enterprises, and various initiatives taken by developed countries in the region to unfold new policies and rework on the existing ones.

Healthcare Interoperability Solutions Market by Region

To know about the assumptions considered for the study, download the pdf brochure

The products and services market is dominated by a few globally established players such as Oracle Health (US), Epic Systems Corporation (US), Infor, Inc. (US), InterSystems Corporation (US), Koninklijke Philips N.V. (Netherlands), Veradigm LLC (US), Cognizant (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), Merative (US), Medical Information Technology, Inc. (US), Lyniate (US), OSP Labs (US), Orion Health Group of Companies (New Zealand), Onyx Technology LLC (US). Some other players in the market include ViSolve (US), Jitterbit (US), iNTERFACEWARE Inc. (Canada), Virtusa Corp. (US), Consensus Cloud Solutions Inc. (US), MphRx (US), Wipro (India), eMids (US), Nalashaa (US), Deevita LLC (US).

Healthcare Interoperability Solutions Market Report Scope:

Report Metric

Details

Market size available for years

2020–2027

Base year considered

2021

Forecast period

2022–2027

Forecast units

Million/Billion (USD)

Segments covered

Type, level of Interoperability, software solution, end user, healthcare providers and region.

Geographies covered

North America, Europe, Asia Pacific, Latin America, and Middle East and Africa

Companies covered

Oracle Health (US), Epic Systems Corporation (US), Infor, Inc. (US), InterSystems Corporation (US), Koninklijke Philips N.V. (Netherlands), Veradigm LLC (US), Cognizant (US), Change Healthcare (US), NextGen Healthcare, Inc. (US), Merative (US), Medical Information Technology, Inc. (US), Lyniate (US), OSP Labs (US), Orion Health Group of Companies (New Zealand), Onyx Technology LLC (US). Some other players in the market include ViSolve (US), Jitterbit (US), iNTERFACEWARE Inc. (Canada), Virtusa Corp. (US), Consensus Cloud Solutions Inc. (US), MphRx (US), Wipro (India), eMids (US), Nalashaa (US), Deevita LLC (US).

The study categorizes the healthcare interoperability solutions market based on product, type, technology, application, animal type, end user at regional and global level.

By Type

  • Introduction
  • Software Solutions
  • Services

By Software Solutions

  • Introduction
  • EHR interoperability solutions
  • Lab system interoperability solutions
  • Imaging system interoperability solutions
  • Healthcare information exchange interoperability solutions
  • Enterprise interoperability solutions
  • Other healthcare interoperability solutions.

By level of Interoperability

  • Introduction
  • Foundational Interoperability
  • Structural Interoperability
  • Semantic Interoperability

By End User

  • Introduction
  • Healthcare Providers
  • Healthcare Payers
  • Pharmacies

By Healthcare Providers

  • Introduction
  • Hospitals & Clinics
  • Long-term Care centers
  • Diagnostics & Imaging centers
  • Other Healthcare Providers

By Region

  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Netherlands
    • Rest Of Europe
  • Asia Pacific
    • Japan
    • Australia
    • Rest of APAC
  • Latin America
  • Middle East & Africa

Recent Developments

  • In November 2022, Nextge Healthcare (US) acquired TSI Healthcare (US) to expand its presence in key specialties, including rheumatology, pulmonology, and cardiology.
  • In October 2022, Lyniate (US) partnered with CyncHealth (US) to help healthcare providers and health networks, payers, and public health departments power more meaningful data exchange.
  • In September 2022, Lyniate (US) partnered with BrightInsight (US) to improve Information Exchange for Regulated Digital Health Solutions Built on the BrightInsight Platform.
  • In July 2022, Intersystem Corporation (US) partnered with Bedfordshire Hospitals NHS Foundation Trust to develop a new shared health and care record, which is being rolled out across Bedfordshire and Luton.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 29)
    1.1 STUDY OBJECTIVES 
    1.2 MARKET DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
           1.2.2 MARKETS COVERED
                    FIGURE 1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION
           1.2.3 YEARS CONSIDERED
    1.3 CURRENCY CONSIDERED 
    1.4 STAKEHOLDERS 
    1.5 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 33)
    2.1 RESEARCH APPROACH 
          FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    2.1.2.1 Primary sources
                    2.1.2.2 Key data from primary sources
                    2.1.2.3 Insights from primary experts
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.2 MARKET SIZE ESTIMATION 
          FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 5 CAGR PROJECTIONS: MARKET
           2.2.1 TOP-DOWN APPROACH
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 6 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET RANKING ANALYSIS 
    2.5 STUDY ASSUMPTIONS 
    2.6 RESEARCH LIMITATIONS 
           2.6.1 METHODOLOGY-RELATED LIMITATIONS
           2.6.2 SCOPE-RELATED LIMITATIONS
    2.7 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT: MARKET
    2.8 IMPACT OF ECONOMIC RECESSION ON MARKET 
           2.8.1 IMPACT OF RUSSIA–UKRAINE WAR
           2.8.2 IMPACT OF INFLATION
 
3 EXECUTIVE SUMMARY (Page No. - 46)
    FIGURE 7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 8 MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 9 MARKET, BY INTEROPERABILITY LEVEL, 2022 VS. 2027 (USD MILLION)
    FIGURE 10 MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 11 GEOGRAPHICAL SNAPSHOT OF MARKET
 
4 PREMIUM INSIGHTS (Page No. - 52)
    4.1 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET OVERVIEW 
          FIGURE 12 GOVERNMENT INITIATIVES FOR ENHANCED PATIENT CARE AND SAFETY TO DRIVE MARKET
    4.2 ASIA PACIFIC: MARKET, BY TYPE AND COUNTRY (2021) 
          FIGURE 13 SERVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021
    4.3 MARKET: GEOGRAPHICAL GROWTH OPPORTUNITIES 
          FIGURE 14 ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
    4.4 REGIONAL MIX: MARKET (2022–2027) 
          FIGURE 15 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD
    4.5 MARKET: DEVELOPED VS. DEVELOPING MARKETS, 2022 VS. 2027 
          FIGURE 16 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
 
5 MARKET OVERVIEW (Page No. - 56)
    5.1 INTRODUCTION 
    5.2 MARKET DYNAMICS 
          FIGURE 17 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Increasing demand for efficient and cost-effective healthcare delivery
                    5.2.1.2 Government initiatives and regulations to enhance patient care and safety
                    5.2.1.3 Emergence of new medical technologies
                    5.2.1.4 Growing adoption of electronic health records
           5.2.2 RESTRAINTS
                    5.2.2.1 Lack of accurate interoperability solutions across healthcare supply chain
                    5.2.2.2 Lack of standards and protocols in IT businesses
                    5.2.2.3 Use of outdated legacy systems in hospitals and clinic chains
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing markets for healthcare interoperability solutions in developing countries
                    5.2.3.2 Advancements in software technology for real-time data exchange
           5.2.4 CHALLENGES
                    5.2.4.1 Increasing complexity due to lack of consistent data
                    5.2.4.2 Shortage of skilled healthcare IT professionals
                    5.2.4.3 Patient data security and privacy concerns in healthcare industry
    5.3 PRICING ANALYSIS 
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 18 VALUE CHAIN ANALYSIS OF MARKET
    5.5 ECOSYSTEM ANALYSIS 
          FIGURE 19 ECOSYSTEM ANALYSIS OF MARKET
    5.6 TECHNOLOGY ANALYSIS 
           5.6.1 APPLICATION PROGRAMMING INTERFACES
           5.6.2 CLOUD-BASED SOLUTIONS
           5.6.3 BLOCKCHAIN TECHNOLOGY
           5.6.4 FAST HEALTHCARE INTEROPERABILITY RESOURCES
           5.6.5 ARTIFICIAL INTELLIGENCE
           5.6.6 MACHINE LEARNING
    5.7 KEY CONFERENCES AND EVENTS IN 2023 
          TABLE 2 MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
    5.8 REGULATORY ANALYSIS 
           5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 3 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 4 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 5 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
                    TABLE 6 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
           5.8.2 LAWS, REGULATIONS, AND STANDARDS
                    TABLE 7 KEY REGULATIONS AND STANDARDS GOVERNING HEALTHCARE INTEROPERABILITY TECHNOLOGIES GLOBALLY
    5.9 PORTER'S FIVE FORCES ANALYSIS 
          FIGURE 20 PORTER’S FIVE FORCES ANALYSIS IN MARKET
          TABLE 8 MARKET: PORTER’S FIVE FORCES ANALYSIS
    5.10 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
                     TABLE 9 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS (%)
           5.10.2 BUYING CRITERIA
                     FIGURE 22 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
                     TABLE 10 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
 
6 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE (Page No. - 76)
    6.1 INTRODUCTION 
          TABLE 11 MARKET, BY TYPE, 2020–2027 (USD MILLION)
    6.2 SOFTWARE SOLUTIONS 
          TABLE 12 MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 13 MARKET FOR SOFTWARE SOLUTIONS, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.1 EHR INTEROPERABILITY SOLUTIONS
                    6.2.1.1 Large installation base of EHR systems to ensure single and continuous readable documents for physicians
                                TABLE 14 EHR INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
                                TABLE 15 EHR INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.2 LAB SYSTEM INTEROPERABILITY SOLUTIONS
                    6.2.2.1 Increasing cost of operations and decreasing reimbursements for laboratory services to boost market
                                TABLE 16 LAB SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
                                TABLE 17 LAB SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.3 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS
                    6.2.3.1 Rising need for data interoperability and increasing usage of smart devices to drive market
                                TABLE 18 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
                                TABLE 19 IMAGING SYSTEM INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.4 HIE INTEROPERABILITY SOLUTIONS
                    6.2.4.1 Large investments by federal governments to propel market
                                TABLE 20 HIE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
                                TABLE 21 HIE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.5 ENTERPRISE INTEROPERABILITY SOLUTIONS
                    6.2.5.1 Advancing software technology and rising demand for expanded care delivery to augment market
                                TABLE 22 ENTERPRISE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
                                TABLE 23 ENTERPRISE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           6.2.6 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS
                    TABLE 24 OTHER HEALTHCARE INTEROPERABILITY SOLUTIONS OFFERED BY KEY PLAYERS
                    TABLE 25 OTHER MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    6.3 SERVICES 
           6.3.1 INCREASING ADOPTION OF HEALTHCARE IT INTEGRATION SERVICES BY PROVIDERS TO AUGMENT MARKET
                    TABLE 26 SERVICES OFFERED BY KEY PLAYERS
                    TABLE 27 MARKET FOR SERVICES, BY COUNTRY, 2020–2027 (USD MILLION)
 
7 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY INTEROPERABILITY LEVEL (Page No. - 92)
    7.1 INTRODUCTION 
          TABLE 28 MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
    7.2 FOUNDATIONAL INTEROPERABILITY 
           7.2.1 NEED FOR SAFE AND ACCURATE DATA EXCHANGE ACROSS DISPARATE SYSTEMS TO FUEL MARKET
                    TABLE 29 MARKET FOR FOUNDATIONAL INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
    7.3 STRUCTURAL INTEROPERABILITY 
           7.3.1 STRUCTURAL INTEROPERABILITY TO ENSURE INTERPRETATION OF DATA EXCHANGE BETWEEN SYSTEMS AT DATA FIELD LEVEL
                    TABLE 30 MARKET FOR STRUCTURAL INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
    7.4 SEMANTIC INTEROPERABILITY 
           7.4.1 SEMANTIC INTEROPERABILITY TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
                    TABLE 31 MARKET FOR SEMANTIC INTEROPERABILITY, BY COUNTRY, 2020–2027 (USD MILLION)
 
8 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY END USER (Page No. - 98)
    8.1 INTRODUCTION 
          TABLE 32 MARKET, BY END USER, 2020–2027 (USD MILLION)
    8.2 HEALTHCARE PROVIDERS 
          TABLE 33 MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 34 MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2020–2027 (USD MILLION)
           8.2.1 HOSPITALS & CLINICS
                    8.2.1.1 Increasing patient volume and rising need to reduce errors in data management to augment market
                                TABLE 35 HOSPITALS & CLINICS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           8.2.2 LONG-TERM CARE CENTERS
                    8.2.2.1 Increasing number of care centers and need to maintain compliance with medical reforms to propel market
                                TABLE 36 LONG-TERM CARE CENTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           8.2.3 DIAGNOSTIC & IMAGING CENTERS
                    8.2.3.1 Increasing volume of clinical data and need to streamline imaging workflows to drive market
                                TABLE 37 DIAGNOSTIC & IMAGING CENTERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
           8.2.4 OTHER HEALTHCARE PROVIDERS
                    TABLE 38 OTHER HEALTHCARE PROVIDERS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
    8.3 HEALTHCARE PAYERS 
           8.3.1 ADOPTION OF HEALTHCARE INTEROPERABILITY BY PAYERS TO DECREASE HOSPITAL STAYS AND REPEAT TESTS
                    TABLE 39 MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2020–2027 (USD MILLION)
    8.4 PHARMACIES 
           8.4.1 PHARMACIES TO USE HEALTHCARE INFORMATION EXCHANGE SOLUTIONS FOR INDIVIDUALIZED PATIENT CARE AND SUPPORT
                    TABLE 40 MARKET FOR PHARMACIES, BY COUNTRY, 2020–2027 (USD MILLION)
 
9 HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY REGION (Page No. - 109)
    9.1 INTRODUCTION 
          TABLE 41 MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.2 NORTH AMERICA 
          FIGURE 23 NORTH AMERICA: MARKET SNAPSHOT
          TABLE 42 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 43 NORTH AMERICA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 44 NORTH AMERICA: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 45 NORTH AMERICA: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
          TABLE 46 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
          TABLE 47 NORTH AMERICA: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
           9.2.1 US
                    9.2.1.1 Growing need to curtail healthcare costs to drive market
                                TABLE 48 US: KEY MACROINDICATORS
                                TABLE 49 US: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 50 US: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 51 US: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
                                TABLE 52 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                TABLE 53 US: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
           9.2.2 CANADA
                    9.2.2.1 Increasing healthcare digitization to support market
                                TABLE 54 CANADA: KEY MACROINDICATORS
                                TABLE 55 CANADA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 56 CANADA: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 57 CANADA: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
                                TABLE 58 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                TABLE 59 CANADA: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
    9.3 EUROPE 
          TABLE 60 EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 61 EUROPE: MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 62 EUROPE: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 63 EUROPE: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
          TABLE 64 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
          TABLE 65 EUROPE: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
           9.3.1 GERMANY
                    9.3.1.1 Modernized healthcare system and increased healthcare expenditure to augment market
                                TABLE 66 GERMANY: KEY MACROINDICATORS
                                TABLE 67 GERMANY: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 68 GERMANY: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 69 GERMANY: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
                                TABLE 70 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                TABLE 71 GERMANY: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
           9.3.2 UK
                    9.3.2.1 Government initiatives and NHS programs to drive demand
                                TABLE 72 UK: KEY MACROINDICATORS
                                TABLE 73 UK: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 74 UK: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 75 UK: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
                                TABLE 76 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                TABLE 77 UK: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
           9.3.3 FRANCE
                    9.3.3.1 Government measures to curtail healthcare expenditures to fuel market
                                TABLE 78 FRANCE: KEY MACROINDICATORS
                                TABLE 79 FRANCE: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 80 FRANCE: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 81 FRANCE: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
                                TABLE 82 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                TABLE 83 FRANCE: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
           9.3.4 ITALY
                    9.3.4.1 Increasing government initiatives in HCIT technology implementation to aid market
                                TABLE 84 ITALY: KEY MACROINDICATORS
                                TABLE 85 ITALY: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 86 ITALY: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 87 ITALY: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
                                TABLE 88 ITALY: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                TABLE 89 ITALY: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
           9.3.5 NETHERLANDS
                    9.3.5.1 Robust healthcare infrastructure and eHealth initiatives to propel market
                                TABLE 90 NETHERLANDS: KEY MACROINDICATORS
                                TABLE 91 NETHERLANDS: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 92 NETHERLANDS: SOLUTIONS MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 93 NETHERLANDS: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
                                TABLE 94 NETHERLANDS: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                TABLE 95 NETHERLANDS: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
           9.3.6 REST OF EUROPE
                    TABLE 96 REST OF EUROPE: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 97 REST OF EUROPE: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 98 REST OF EUROPE: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
                    TABLE 99 REST OF EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
                    TABLE 100 REST OF EUROPE: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
    9.4 ASIA PACIFIC 
          FIGURE 24 ASIA PACIFIC: MARKET SNAPSHOT
          TABLE 101 ASIA PACIFIC: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
          TABLE 102 ASIA PACIFIC: MARKET, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 103 ASIA PACIFIC: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 104 ASIA PACIFIC: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
          TABLE 105 ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
          TABLE 106 ASIA PACIFIC: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
           9.4.1 JAPAN
                    9.4.1.1 Japan to be largest healthcare interoperability market in Asia Pacific during forecast period
                                TABLE 107 JAPAN: KEY MACROINDICATORS
                                TABLE 108 JAPAN: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 109 JAPAN: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 110 JAPAN: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
                                TABLE 111 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                TABLE 112 JAPAN: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
           9.4.2 AUSTRALIA
                    9.4.2.1 Increasing government initiatives for better clinical communication to drive market
                                TABLE 113 AUSTRALIA: KEY MACROINDICATORS
                                TABLE 114 AUSTRALIA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 115 AUSTRALIA: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
                                TABLE 116 AUSTRALIA: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
                                TABLE 117 AUSTRALIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                TABLE 118 AUSTRALIA: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
           9.4.3 REST OF ASIA PACIFIC
                    TABLE 119 REST OF ASIA PACIFIC: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 120 REST OF ASIA PACIFIC: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 121 REST OF ASIA PACIFIC: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
                    TABLE 122 REST OF ASIA PACIFIC: MARKET, BY END USER, 2020–2027 (USD MILLION)
                    TABLE 123 REST OF ASIA PACIFIC: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
    9.5 LATIN AMERICA 
           9.5.1 IMPLEMENTATION OF FAVORABLE GOVERNMENT INITIATIVES TO DRIVE MARKET
                    TABLE 124 LATIN AMERICA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 125 LATIN AMERICA: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 126 LATIN AMERICA: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
                    TABLE 127 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                    TABLE 128 LATIN AMERICA: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
    9.6 MIDDLE EAST & AFRICA 
           9.6.1 INCREASED ESTABLISHMENT OF NEW HOSPITALS TO DRIVE MARKET
                    TABLE 129 MIDDLE EAST & AFRICA: HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 130 MIDDLE EAST & AFRICA: MARKET FOR SOFTWARE SOLUTIONS, BY TYPE, 2020–2027 (USD MILLION)
                    TABLE 131 MIDDLE EAST & AFRICA: MARKET, BY INTEROPERABILITY LEVEL, 2020–2027 (USD MILLION)
                    TABLE 132 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                    TABLE 133 MIDDLE EAST & AFRICA: MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
 
10 COMPETITIVE LANDSCAPE (Page No. - 157)
     10.1 INTRODUCTION 
     10.2 KEY STRATEGIES ADOPTED BY PLAYERS IN HEALTHCARE INTEROPERABILITY SOLUTIONS MARKET 
             TABLE 134 MARKET: KEY DEVELOPMENTS (JANUARY 2019–MARCH 2023)
     10.3 MARKET RANKING OF KEY PLAYERS IN MARKET 
             FIGURE 25 MARKET: MARKET RANKING OF KEY PLAYERS (2022)
     10.4 MARKET SHARE ANALYSIS 
             10.4.1 MARKET
                        TABLE 135 MARKET SHARE, BY KEY PLAYER, 2021
     10.5 COMPETITIVE EVALUATION QUADRANT FOR KEY PLAYERS 
             10.5.1 STARS
             10.5.2 EMERGING LEADERS
             10.5.3 PERVASIVE PLAYERS
             10.5.4 PARTICIPANTS
                        FIGURE 26 MARKET: COMPETITIVE LEADERSHIP MAPPING (2022)
     10.6 COMPETITIVE EVALUATION QUADRANT FOR START-UPS/SMES 
             10.6.1 PROGRESSIVE COMPANIES
             10.6.2 DYNAMIC COMPANIES
             10.6.3 STARTING BLOCKS
             10.6.4 RESPONSIVE COMPANIES
                        FIGURE 27 MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES (2022)
     10.7 COMPETITIVE BENCHMARKING 
             10.7.1 PRODUCT FOOTPRINT OF PLAYERS IN MARKET
                        TABLE 136 COMPANY PRODUCT FOOTPRINT
             10.7.2 REGIONAL FOOTPRINT OF PLAYERS IN MARKET
                        TABLE 137 COMPANY REGION FOOTPRINT
             10.7.3 FOOTPRINT OF PLAYERS IN MARKET
                        TABLE 138 COMPANY FOOTPRINT
     10.8 COMPETITIVE SCENARIO 
             10.8.1 KEY PRODUCT/SERVICE LAUNCHES AND APPROVALS
                        TABLE 139 KEY PRODUCT/SERVICE LAUNCHES AND APPROVALS, 2019–2022
             10.8.2 KEY DEALS
                        TABLE 140 KEY DEALS, 2019–2022
 
11 COMPANY PROFILES (Page No. - 171)
     11.1 KEY PLAYERS 
(Business Overview, Products/Services/Solutions offered, Recent Developments, and MnM View)*
             11.1.1 ORACLE HEALTH
                        TABLE 141 ORACLE HEALTH: COMPANY OVERVIEW
                        FIGURE 28 ORACLE HEALTH: COMPANY SNAPSHOT (2021)
             11.1.2 EPIC SYSTEMS CORPORATION
                        TABLE 142 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW
             11.1.3 INFOR, INC.
                        TABLE 143 INFOR, INC.: COMPANY OVERVIEW
                        FIGURE 29 INFOR, INC.: COMPANY SNAPSHOT (2019)
             11.1.4 INTERSYSTEMS CORPORATION
                        TABLE 144 INTERSYSTEMS CORPORATION: COMPANY OVERVIEW
             11.1.5 KONINKLIJKE PHILIPS N.V.
                        TABLE 145 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
                        FIGURE 30 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2021)
             11.1.6 VERADIGM LLC
                        TABLE 146 VERADIGM LLC: COMPANY OVERVIEW
                        FIGURE 31 VERADIGM LLC: COMPANY SNAPSHOT (2021)
             11.1.7 COGNIZANT
                        TABLE 147 COGNIZANT: COMPANY OVERVIEW
                        FIGURE 32 COGNIZANT: COMPANY SNAPSHOT (2021)
             11.1.8 CHANGE HEALTHCARE
                        TABLE 148 CHANGE HEALTHCARE: COMPANY OVERVIEW
                        FIGURE 33 CHANGE HEALTHCARE: COMPANY SNAPSHOT (2021)
             11.1.9 NEXTGEN HEALTHCARE, INC.
                        TABLE 149 NEXTGEN HEALTHCARE, INC.: COMPANY OVERVIEW
                        FIGURE 34 NEXTGEN HEALTHCARE, INC.: COMPANY SNAPSHOT (2020)
             11.1.10 MERATIVE
                        TABLE 150 MERATIVE: COMPANY OVERVIEW
             11.1.11 MEDICAL INFORMATION TECHNOLOGY, INC.
                        TABLE 151 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY OVERVIEW
                        FIGURE 35 MEDICAL INFORMATION TECHNOLOGY, INC.: COMPANY SNAPSHOT (2019)
             11.1.12 LYNIATE
                        TABLE 152 LYNIATE: COMPANY OVERVIEW
             11.1.13 OSP LABS
                        TABLE 153 OSP LABS: COMPANY OVERVIEW
             11.1.14 ORION HEALTH GROUP OF COMPANIES
                        TABLE 154 ORION HEALTH GROUP OF COMPANIES: COMPANY OVERVIEW
                        FIGURE 36 ORION HEALTH GROUP OF COMPANIES: COMPANY SNAPSHOT (2021)
             11.1.15 ONYX TECHNOLOGY LLC
                        TABLE 155 ONYX TECHNOLOGY LLC: COMPANY OVERVIEW
     11.2 OTHER PLAYERS 
             11.2.1 VISOLVE
                        TABLE 156 VISOLVE: COMPANY OVERVIEW
             11.2.2 JITTERBIT
                        TABLE 157 JITTERBIT: COMPANY OVERVIEW
             11.2.3 INTERFACEWARE INC.
                        TABLE 158 INTERFACEWARE INC.: COMPANY OVERVIEW
             11.2.4 VIRTUSA CORP.
                        TABLE 159 VIRTUSA CORP.: COMPANY OVERVIEW
                        FIGURE 37 VIRTUSA CORP.: COMPANY SNAPSHOT (2020)
             11.2.5 CONSENSUS CLOUD SOLUTIONS INC.
                        TABLE 160 CONSENSUS CLOUD SOLUTIONS INC.: COMPANY OVERVIEW
             11.2.6 MPHRX
             11.2.7 WIPRO
             11.2.8 EMIDS
             11.2.9 NALASHAA
             11.2.10 DEEVITA LLC
 
* Business Overview, Products/Services/Solutions offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
 
12 APPENDIX (Page No. - 217)
     12.1 DISCUSSION GUIDE 
     12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     12.3 CUSTOMIZATION OPTIONS 
     12.4 RELATED REPORTS 
     12.5 AUTHOR DETAILS 

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Secondary Research

This research study involved the use of comprehensive secondary sources; directories and databases such as D&B, Bloomberg Business, and Factiva; and white papers, annual reports, and company house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global Healthcare interoperability solutions Market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, technology perspectives, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the Healthcare interoperability solutions Market. The primary sources from the demand side include key personnel from hospitals, clinics, physicians’ offices, and healthcare providers and payers.

A breakdown of the primary respondents is provided below:

Healthcare Interoperability Solutions Market Size, and Share

*Others include sales managers, marketing managers, and product managers.

Note: Tiers are defined based on a company’s total revenue, as of 2020: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by type, level of Interoperability,  end user, and region).

Data Triangulation

After arriving at the market size, the total Healthcare interoperability solutions Market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

Global HealthcareInteroperability Solutions Market Size: Top-Down Approach

Healthcare Interoperability Solutions Market Size, and Share

To know about the assumptions considered for the study, Request for Free Sample Report

Market Definition

Healthcare interoperability solutions allow the seamless exchange and interpretation of health-related data amongst healthcare companies and patients for clinical decision-making to offer proprietary control over health information. The market scope includes only interoperable solutions, whereas standalone solutions, such as EHR and HIE, are not included.

Key Stakeholders

  • Healthcare IT Service Providers
  • Healthcare Institutions/Providers (Hospitals, Medical Groups, Physician Practices, Diagnostic Centers, and Outpatient Clinics)
  • Venture Capitalists
  • Government Bodies
  • Corporate Entities
  • Accountable Care Organizations
  • Academic Research Institutes
  • Healthcare Payers
  • Market Research and Consulting Firms
  • Healthcare IT Vendors

Objectives of the Study

  • To To define, describe, and forecast the healthcare interoperability solutions market by type, interoperability level, end user, and region
  • To provide detailed information about the major factors influencing the market growth (drivers, restraints, opportunities, and challenges)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market segments in North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players and comprehensively analyze their market shares and core competencies in the market
  • To track and analyze competitive developments such as partnerships, agreements, and collaborations; mergers & acquisitions; product developments; and geographical expansions in the market

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific Healthcare interoperability solutions Market into India, China, New Zealand and others
  • Further breakdown of the Rest of Europe Healthcare interoperability solutions Market into the Spain, Belgium, Switzerland and others
  • Further breakdown of the Latin America Healthcare interoperability solutions Market into Argentina, Colombia, Chile, and others
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
HIT 6989
Published ON
Mar, 2023
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Healthcare Interoperability Solutions Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback